Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.
Press releases published on August 27, 2025
Alluxio Closes Strong Q2 with Customer Growth, Sub-Millisecond Latency Capability for AI Data & Record MLPerf Storage v2.0 Benchmark Results
GlobeNewswire
·
August 27, 2025
SAN MATEO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alluxio, the AI and data-acceleration platform, today announced strong results for the second quarter of its 2026 fiscal year. During the quarter, the company launched Alluxio Enterprise AI 3.7, a major …
ODYSIGHT.AI TO PARTICIPATE IN THE H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE
GlobeNewswire
·
August 27, 2025
OMER, Israel, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Odysight.AI Inc. (Nasdaq: ODYS), a leading developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), today announced that Einav Brenner, Chief Financial Officer, will …
Critical One Closes CDN$3 Million Private Placement
GlobeNewswire
·
August 27, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Critical One Energy Inc. (formerly Madison Metals Inc.) (“Critical One” or the “Company”) (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF0) …
24/7 Market News: LIXTE Showcases LB-100 at First Global Conference on Oncogenic Signaling Activation as Cancer Therapy
GlobeNewswire
·
August 27, 2025
DENVER, Aug. 27, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, highlights the publication of a new manuscript in Trends in Cancer (July 2025, …
Kailera Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity, today announced …
Cellectar Biosciences to Present Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
GlobeNewswire
·
August 27, 2025
FLORHAM PARK, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the acceptance …
24/7 Market News: Kraig Labs Prepares for High-Profile International Order as Second Production Facility Reaches Full Operational Status
GlobeNewswire
·
August 27, 2025
DENVER, Aug. 27, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and insights, reports that Kraig Biocraft Laboratories (OTCQB: KBLB)(“Kraig Labs” or “the Company”), the …
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
GlobeNewswire
·
August 27, 2025
US Food and Drug Administration (FDA) has granted Fast Track designation for NRX-100 in the treatment of suicidal ideation in patients with depression, including bipolar depression. NRx Pharmaceuticals is making NRX-100 available on an expanded access …
Evaxion to present at several conferences during the second half of 2025
GlobeNewswire
·
August 27, 2025
Evaxion will provide scientific and company updates at numerous conferences in both the US, Europe and Asia during the coming months COPENHAGEN, Denmark, August 27, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company …
Aclaris Therapeutics to Participate in Two September Healthcare Conferences
GlobeNewswire
·
August 27, 2025
WAYNE, Pa., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will …
Annexon Biosciences to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
August 27, 2025
BRISBANE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
GlobeNewswire
·
August 27, 2025
PHILADELPHIA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune …
Acronis and Intel Partner to Deliver Efficient, AI-Driven Threat Detection for Endpoint Devices
GlobeNewswire
·
August 27, 2025
SCHAFFHAUSEN, Switzerland, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, and Intel, today announced Acronis Cyber Protect Cloud’s availability with AI PCs powered by Intel Core Ultra processors, a new …
Soleno Therapeutics to Participate in Upcoming September Conferences
GlobeNewswire
·
August 27, 2025
REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the …
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living …
Septerna to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that management will participate …
Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
GlobeNewswire
·
August 27, 2025
CARLSBAD, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a …
Grace Therapeutics Announces U.S. Food and Drug Administration Acceptance for Review of New Drug Application for GTx-104
GlobeNewswire
·
August 27, 2025
FDA Establishes April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) Comprehensive Data Package Supported by Positive Results from Phase 3 …
Lancaster Resources Completes Acquisition of Lac Iris Polymetallic Project
GlobeNewswire
·
August 27, 2025
VANCOUVER, British Columbia, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF) (“Lancaster”), is pleased to announce that it has acquired a 100% interest in the Lac Iris Polymetallic Project in the James Bay …
Sonoro GOLD Announces increase in Private Placement
GlobeNewswire
·
August 27, 2025
“THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.” VANCOUVER, Canada, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: …